About
Transforming cancer diagnostics through a digital diagnostic platform to improve patient care.
-
2012
An idea was born
Two Utah-based private practice pathologists seeking to build a digital practice, purchase a whole slide imaging system, and recognize the necessity to standardize pre-diagnostic workflow.
-
2013
Lumea is founded
LUMEA is founded to develop standardized workflows for digital pathology, building a platform to link clinic, lab and pathologist in one system. They named it BxLink.
-
2014
Established EU R&D Facility
Partnered with Themis Pathology (Bucharest, Romania) to establish a Histochemistry R&D facility for multi-plexed and improved tissue embedding.
-
2015
BxChip Launched
Established an integrated digital histology lab in a Provo warehouse, to implement and validate nascent technologies, including the BxChip.
-
2016
AI Powered Workflow Commercialized
Incorporated artificial intelligence into the digital imaging of gross tissue biopsy specimens, and commercialized the first AI-powered pathology workflow.
-
2017
Buildout of State-of-the Art HQ
LUMEA digital prostate core mapping is developed and deployed as part of a major multi center FDA validation trial.
-
2018
R&D initiatives in Gastroenterology, Dermatology
LUMEA launches R&D initiatives in Gastroenterology, Dermatology pre-analytics.
LUMEA technologies are adopted in multiple academic centers.
-
2019
Technologies Adopted
LUMEA technologies adopted in a national commercial laboratory.
LUMEA launches R&D initiative for low-cellularity / high value specimens and name it the CytoPod.
Independent clinical trials validate superior tissue handling and cost effectiveness of LUMEA lab workflow and tissue handling technologies.
-
2020
Award of 3 Major Patents
LUMEA spins off its clinical lab into a separate diagnostic services company (PathNet Labs).
LUMEA is awarded 3 major patents relating to tissue handling, point-of-care imaging and the use of artificial intelligence in histology workflow.